Literature DB >> 22322138

Reference values for thrombotic markers in children.

Darintr Sosothikul1, Yaowaree Kittikalayawong, Pattramon Aungbamnet, Chatchai Buphachat, Panya Seksarn.   

Abstract

Thromboembolic events are an increasingly common problem encountered in children. The laboratory diagnosis of thrombotic disorders in children differs from that in adults. To establish the normal reference of natural anticoagulant parameters in children of different age groups, plasma from healthy children between the ages of 2 months and 16 years (n = 127) and adults (n = 30) were assayed for a disintegrin-like and metalloprotease with thrombospondin type 1 domain 13 (ADAMTS-13), von Willebrand factor collagen-binding activity (vWF:CB), tissue factor pathway inhibitor (TFPI), homocyteine and natural anticoagulants. Children were divided into four age groups: less than 1 year, 1-5 years, 6-10 years, and 11-16 years. The reference values for ADAMTS 13, homocysteine, and protein C activity were significantly lower in children of all age groups compared with those in the adults. Similarly, those for protein C antigen, total protein S, free protein S and antithrombin III (AT III) for children less than 1 year were significantly lower than in the adults. On the contrary, TFPI levels were significantly higher in the children for all age groups when compared with the adults. vWF:CB levels were comparable across all groups. There are age-related physiologic differences in ADAMTS-13, TFPI, homocysteine and natural anticoagulants between children and adults. Our data will provide physicians with a useful reference guide in interpreting test results of inhibitors of hemostatic parameters in children suspected of thrombotic disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322138     DOI: 10.1097/MBC.0b013e328350294a

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

1.  Population pharmacokinetics of human antithrombin concentrate in paediatric patients.

Authors:  Brady S Moffett; Rosa Diaz; Marianne Galati; Donald Mahoney; Jun Teruya; Donald L Yee
Journal:  Br J Clin Pharmacol       Date:  2017-08-11       Impact factor: 4.335

2.  Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.

Authors:  Masako Ichiyama; Shouichi Ohga; Masayuki Ochiai; Koichi Tanaka; Yuka Matsunaga; Takeshi Kusuda; Hirosuke Inoue; Masataka Ishimura; Tomohito Takimoto; Yui Koga; Taeko Hotta; Dongchon Kang; Toshiro Hara
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

3.  Hypothyroidism, Sex, and Age Predict Future Thromboembolic Events Among Younger People.

Authors:  Jay A Martinez; Fares Qeadan; Mark R Burge
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population.

Authors:  Natsumon Udomkittivorakul; Werasak Sasanakul; Jakris Eu-Ahsunthornwattana; Ampaiwan Chuansumrit; Patcharee Komwilaisak; Duantida Songdej; Nongnuch Sirachainan
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Determination of Age-Dependent Reference Ranges for Coagulation Tests Performed Using Destiny Plus.

Authors:  Fatma Demet Arslan; Muhittin Serdar; Elif Merve Ari; Mustafa Onur Oztan; Sureyya Hikmet Kozcu; Huseyin Tarhan; Ozgur Cakmak; Merve Zeytinli; Hamit Yasar Ellidag
Journal:  Iran J Pediatr       Date:  2016-04-30       Impact factor: 0.364

6.  Increased tissue factor activity promotes thrombin generation at type 1 diabetes onset in children.

Authors:  Hildegard Jasser-Nitsche; Harald Haidl; Gerhard Cvirn; Sina Pohl; Siegfried Gallistl; Elke Fröhlich-Reiterer; Axel Schlagenhauf
Journal:  Pediatr Diabetes       Date:  2020-08-07       Impact factor: 3.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.